Supporting Access to Alimera Products via AccessAlimera

AccessAlimera

This website, allows healthcare professionals to submit requests, on behalf of patients in their care, for access to Alimera products in countries with no marketing authorisation.

Please follow the steps below to determine whether or not marketing authorisation has already been granted in your country and to make contacting Alimera and our partners simple.

Step 1

Select your country or region from the dropdown to see if Alimera products have already been granted marketing authorisation.

If it has, you will be diverted to the relevant Alimera or partner website where you can make an enquiry for more information on Alimera products.

If your country is not listed please go to Step 2.

Select country or region

ASIA-PACIFIC AUSTRIA BAHRAIN BELGIUM CZECH REPUBLIC EGYPT DENMARK FINLAND FRANCE GERMANY IRAQ IRELAND JORDAN KINGDOM OF SAUDI ARABIA KUWAIT LEBANON LUXEMBOURG NETHERLANDS NORWAY OMAN PORTUGAL QATAR SWEDEN UNITED ARAB EMIRATES UNITED KINGDOM UNITED STATES OF AMERICA YEMEN

Step 2

Where permitted by country regulations, healthcare providers may use the form below to submit questions about Expanded Access to Alimera products in countries with no marketing authorisation. Please complete the form below and our partners at Tanner Pharma Group will aim to be in contact within 48 hours.

Step 2

We see more, together.